Tests a heart MRI scan without contrast for scarring in dialysis patients
Checks a heart MRI scan for scarring in adults with kidney failure on dialysis.
Key facts
- Who runs it
- University of Leicester
- Where
- Leicester, United KingdomSee the site
- Trial code
- Registry title
- Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
- Status
- Recruiting
- People taking part
- 9 people, planned
- Started
- 3 Nov 2019
- Planned end
- 31 Dec 2025
- Type of study
- Observational
- Treatments tested
- Cardiac MRI scan
- Echocardiogram
- Cardiac explantation
- 48-Hour continuous cardiac monitoring
- Blood samples
- Record updated
- 18 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults on haemodialysis for more than 3 months who are on a supportive care register and are expected to die within 12 months. It tests a heart MRI scar measure.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- On haemodialysis for more than 3 months, on the supportive care register, with death expected within the next 12 months
- Earlier treatment
- Must have been on haemodialysis for more than 3 months
Main reasons for not taking part
- Cannot have an MRI scan (for example pacemaker, incompatible metal implants, claustrophobia)
- Expected or possible infiltrative heart muscle disease (for example amyloidosis)
- Cannot give informed consent
- Cannot understand written and spoken English
- Does not consent to donating the heart for research after death
This trial only enrols participants on dialysis. The registry sentence this rests on: Prevalent haemodialysis patient (more than 3 months)
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Prevalent haemodialysis patient (more than 3 months)
- Active on the supportive care register with anticipated death in the subsequent 12 months
- Able to give informed consent
- Consent to donation of heart for research following death
- Able to understand written and verbal explanations in English
Who cannot take part
- Contraindication to MRI scan (e.g. pacemaker, incompatible metallic implants, claustrophobia)
- Patients with expected or potential infiltrative cardiomyopathy (e.g. amyloidosis)
- Unable to give informed consent
- Unable to understand written and verbal explanations in English
Where in United Kingdom
- University Hospitals of Leicester NHS TrustLeicester, United KingdomContact: James Burton, FRCPTaking people
About the trial
What the trial wants to find out
There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1 mapping, may provide a solution to this. To assess the accuracy of this novel technique in dialysis patients, it is essential to undertake a study which compares native T1 mapping to actual levels of scarring in the hearts of patients on dialysis.
The group in the trial
- Haemodialysis patients
The plans for patient recruitment were developed in partnership with our local haemodialysis patient participation and involvement group. Patients will be identified from the supportive care register established for haemodialysis patients in Leicester in 2008. Inclusion: * Prevalent haemodialysis patient (more than 3 months) * Active on the supportive care register with anticipated death in the subsequent 12 months * Able to give informed consent * Consent to donation of heart for research following death * Able to understand written and verbal explanations in English Exclusion: * Contraindication to MRI scan (e.g. pacemaker, incompatible metallic implants, claustrophobia) * Patients with expected or potential infiltrative cardiomyopathy (e.g. amyloidosis) * Unable to give informed consent * Unable to understand written and verbal explanations in English
Treatment: Cardiac MRI scan, Echocardiogram, Cardiac explantation, 48-Hour continuous cardiac monitoring, and Blood samples
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Validating the Accuracy of Novel, Non-contrast, Cardiac Magnetic resOnaNce Imaging in Defining Myocardial FIbRosis in Patients With End-stage Renal Disease on haeModialysis: the CONFIRM Study
- Plain-language title
- Tests a heart MRI scan without contrast for scarring in dialysis patientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 April 2025